---
type: "Symbol"
title: "Huaren Health (301408.SZ) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/301408.SZ/topics.md"
symbol: "301408.SZ"
parent: "https://longbridge.com/en/quote/301408.SZ.md"
count: 3
datetime: "2026-03-15T12:58:56.562Z"
locales:
  - [en](https://longbridge.com/en/quote/301408.SZ/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301408.SZ/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301408.SZ/topics.md)
---

# Huaren Health (301408.SZ) — Community Discussions

### [Chinese Health's stock price surged over 10% in a single day! During the industry cycle shift, pharmaceutical retail needs a 'digital twin'.](https://longbridge.com/en/topics/37198399.md)

- Author: [医药研究社](https://longbridge.com/en/profiles/15545088.md)
- Datetime: 2025-12-17T13:07:06.000Z
- Comments: 0
- AI healthcare is trending again. It is reported that the AI health app "Ant Ah Fu" under Ant Group has seen a surge in downloads after its release, ranking third on Apple's overall app chart. 

### [The innovative drug sector welcomes multiple positive news again! E Fund Innovative Drug ETF (517380) has seen continuous capital inflows for two consecutive days, while the Biopharmaceutical ETF (159859) recorded a net subscription of over 28 million during the session.](https://longbridge.com/en/topics/31220679.md)

- Author: [格隆汇](https://longbridge.com/en/profiles/11813099.md)
- Datetime: 2025-06-27T03:07:42.000Z
- Comments: 0
- Gelonghui June 27th｜Today, innovative drug concept stocks fluctuated and strengthened, with Mabwell Biopharma hitting a 20cm limit-up, Huaren Health and Jinbo Biotech rising over 10%, Biopharma ETF (1

### [Peers 'hit the brakes,' while Huaren Health continues its 'counter-cyclical' strategy with a 3 billion yuan acquisition. Why the 'rebellion'?](https://longbridge.com/en/topics/30002468.md)

- Author: [医药研究社](https://longbridge.com/en/profiles/15545088.md)
- Datetime: 2025-05-23T13:11:24.000Z
- Comments: 0
- It is increasingly confirmed that Huaren Health is the "contrarian" in the pharmaceutical retail chain industry. In the era of stock competition, when peers are starting to "hit the brakes

## References

- [Huaren Health (301408.SZ)](https://longbridge.com/en/quote/301408.SZ.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301408.SZ/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301408.SZ/topics.md)